<code id='4ABF8ED3C9'></code><style id='4ABF8ED3C9'></style>
    • <acronym id='4ABF8ED3C9'></acronym>
      <center id='4ABF8ED3C9'><center id='4ABF8ED3C9'><tfoot id='4ABF8ED3C9'></tfoot></center><abbr id='4ABF8ED3C9'><dir id='4ABF8ED3C9'><tfoot id='4ABF8ED3C9'></tfoot><noframes id='4ABF8ED3C9'>

    • <optgroup id='4ABF8ED3C9'><strike id='4ABF8ED3C9'><sup id='4ABF8ED3C9'></sup></strike><code id='4ABF8ED3C9'></code></optgroup>
        1. <b id='4ABF8ED3C9'><label id='4ABF8ED3C9'><select id='4ABF8ED3C9'><dt id='4ABF8ED3C9'><span id='4ABF8ED3C9'></span></dt></select></label></b><u id='4ABF8ED3C9'></u>
          <i id='4ABF8ED3C9'><strike id='4ABF8ED3C9'><tt id='4ABF8ED3C9'><pre id='4ABF8ED3C9'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:994
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Tocagen's brain cancer gene therapy trial continues. Investors worry
          Tocagen's brain cancer gene therapy trial continues. Investors worry

          MichelleMonje/StanfordUniversity/NIHTocagen(TOCA)saidTuesdaythataPhase3clinicaltrialinvolvinganovelg

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Stanford president's case begs question: Who takes blame?

          PalmDriveattheentrancetoStanfordUniversity.BrianFrankforSTATTheresignationofMarcTessier-Lavigneaspre